Breaking News

A Harvard Medical School-led team applied their SNP-seq and FREP approach to identify nearly 150 candidate functional SNPs for juvenile idiopathic arthritis.

Researchers looked at the prevalence and effects of whole-genome duplication events across cancers using targeted sequenced data for almost 10,000 advanced cases.

The test detects and distinguishes pertussis and parapertussis in nasopharyngeal swab samples. It is for use on the Quidel's Solana MDx instrument.

The company is developing a proprietary technology for the detection of RNA- and DNA-based genetic alterations in blood samples.

The product is designed to provide customers with personalized information about their nutrition, metabolisms, and eating behaviors.

Silicon Valley VC firm DFJ led the investment in Verge, which is applying machine learning to the development of new drugs for Parkinson's and ALS.

Last week, GenomeWeb's readers were most interested in a new in situ RNA sequencing technology that maintains 3D spatial information at single-cell resolution.

NewStem is developing a technology that uses human haploid embryonic stem cells to predict cancer drug resistance.

The USDA Food Safety and Inspection Service will use the company's 3M Molecular Detection System for pathogen detection.

Array-based copy number analysis of primary intrahepatic cholangiocarcinomas and matched lymph node metastases revealed a tumor cluster with ties to survival.

The agreement extends the reach of Biocept's Target Selector testing to a large new region and brings its total reach to 17 countries outside the US.

Using more than 16,000 tick samples submitted by individuals in the mainland US and Puerto Rico, researchers documented tick species and infection by four pathogens.

JPK provides microscopy instrumentation for biomolecular and cellular imaging, as well as force measurements on single molecules, cells, and tissues.

The coverage decision limits the test mainly to patients with advanced lung cancers who haven't been genomically profiled and who can't receive tissue testing.

Deepwater rice in the Philippines.

A search for genetic contributors to flood-tolerant rice led to a distinct version of the gibberellin biosynthesis gene SD1.

Researchers sequenced mothers who experienced preterm birth and found a possible role for steroid signaling in birth timing.

With Pacific Biosciences sequencing, researchers found DNA N6-methyladenine modifications in the human genome and noted a role for it in tumorigenesis.

Otzi gastrointestinal tract.

An analysis of stomach and gastrointestinal samples suggests the Iceman munched on a high-fat diet of ibex, red deer, and einkorn plants before his final hike.

The firm anticipates that the award will accelerate the development of its over-the-counter and professional-use influenza and multiplex respiratory pathogen tests. 

The firm said it will offer 4.5 million shares of its common stock at $20 per share. It expects to close its follow-on public offering on July 16.

The plaintiffs claim that Qiagen's QIAseq kits infringe Archer's US Patent No. 10,017,810, which covers parts of its Anchored Multiplex PCR (AMP) technology.

OrigiMed is a Shanghai, China-based company focusing on the development of new oncology assays.

Pages

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.